Daratumumab treatment shows promise for high-risk smoldering multiple myeloma in phase 3 trial Post author: Post published:December 10, 2024 Post category:uncategorized Post comments:0 Comments A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). You Might Also Like Imaging approach provides objective evidence for the involvement of neck muscles in primary headaches November 29, 2023 Semen microbiota might play a crucial role in influencing male fertility January 18, 2024 New insights into pain mechanisms related to viral infections October 15, 2024 Leave a Reply Cancel replyYou must be logged in to post a comment.
Imaging approach provides objective evidence for the involvement of neck muscles in primary headaches November 29, 2023